You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MC4R

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overweight Trial in United States (RM-493, Placebo)

Completed
  • Overweight
  • Miami, Florida
  • +5 more
Nov 14, 2022

Genetic Forms of Extreme Obesity Trial in Columbus, Edmonton

Completed
  • Genetic Forms of Extreme Obesity
    • Columbus, Ohio
    • +1 more
    Apr 30, 2021

    Genetic Obesity Trial in Spain, United Kingdom, United States (Setmelanotide, Placebo)

    Recruiting
    • Genetic Obesity
    • Dearborn, Michigan
    • +13 more
    Jun 14, 2022

    Bardet Biedl Syndrome (BBS), Alström Syndrome (AS) Trial in Worldwide (Setmelanotide, Placebos)

    Completed
    • Bardet Biedl Syndrome (BBS)
    • Alström Syndrome (AS)
    • San Diego, California
    • +11 more
    Jul 19, 2021

    Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

    Not yet recruiting
    • Recurrent Severe Aplastic Anemia
    • Refractory Severe Aplastic Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Feb 23, 2023

    Leptin Receptor Deficiency Obesity Trial in Worldwide (setmelanotide, Placebo)

    Completed
    • Leptin Receptor Deficiency Obesity
    • New York, New York
    • +6 more
    Jan 26, 2021

    ALS, FTD Trial in Worldwide (WVE-004, Placebo)

    Active, not recruiting
    • ALS
    • FTD
    • North Ryde, New South Wales, Australia
    • +16 more
    Feb 2, 2023

    Pro-opiomelanocortin (POMC) Deficiency Obesity Trial in Worldwide (Setmelanotide, Placebo)

    Completed
    • Pro-opiomelanocortin (POMC) Deficiency Obesity
    • Scottsdale, Arizona
    • +6 more
    Jan 26, 2021

    Pregnancy Early, Outcome, Adverse Birth, Lifestyle Factors Trial in Rotterdam (Standard care, Lifestyle program)

    Recruiting
    • Pregnancy Early
    • +6 more
    • Standard care
    • Lifestyle program
    • Rotterdam, Netherlands
      Erasmus MC
    May 13, 2023

    Skin Cancer Trial in Salt Lake City (Education, Action Plan, UV Photo)

    Not yet recruiting
    • Skin Cancer
    • Education
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 1, 2022

    Type2 Diabetes, Dyslipidemia Trial in Worldwide (K-877, Placebo)

    Terminated
    • Type2 Diabetes
    • Dyslipidemia
    • Birmingham, Alabama
    • +887 more
    Dec 20, 2022

    Plaque Psoriasis Trial in Bulgaria, Poland, Slovakia (GLPG3667, Placebo)

    Completed
    • Plaque Psoriasis
    • Sofia, Bulgaria
    • +6 more
    May 26, 2021

    Ultra-high-field Brain MRI in Multiple Sclerosis

    Not yet recruiting
    • Multiple Sclerosis
    • Brain MRI (3T, 7T, 9.4T)
    • Geleen, Limburg, Netherlands
      Zuyderland MC
    Jan 30, 2023

    Peanut Allergy Trial in Worldwide (Viaskin Peanut 50 mcg, Viaskin Peanut 100 mcg, Viaskin Peanut 250 mcg)

    Completed
    Has Results
    • Peanut Allergy
    • Viaskin Peanut 50 mcg
    • +3 more
    • San Diego, California
    • +23 more
    Sep 28, 2021

    Advance Care Planning Trial (Trauma-Informed Care-adapted and Checklist-guided ACP intervention)

    Not yet recruiting
    • Advance Care Planning
    • Trauma-Informed Care-adapted and Checklist-guided ACP intervention
    • (no location specified)
    Nov 14, 2023

    Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)

    Completed
    Has Results
    • Atopic Dermatitis
    • Abrocitinib 200 mg
    • Dupilumab 300 mg
    • Birmingham, Alabama
    • +150 more
    Jun 9, 2022

    Healthy Trial (3,4-methylenedioxymethamphetamine, S-3,4-methylenedioxymethamphetamine, R-3,4-methylenedioxymethamphetamine (125

    Recruiting
    • Healthy
    • Basel, Switzerland
      University Hospital Basel
    Nov 1, 2022

    COPD Trial in Worldwide (Ensifentrine, Placebo)

    Active, not recruiting
    • Chronic Obstructive Pulmonary Disease
    • Peoria, Arizona
    • +133 more
    Dec 5, 2022

    Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)

    Recruiting
    • Allergy
    • SQ tree SLIT-tablet
    • Placebo
    • Vienna, Austria
    • +83 more
    Dec 21, 2022

    Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

    Not yet recruiting
    • Melanoma (Skin)
    • +5 more
    • Iowa City, Iowa
    • +2 more
    Dec 8, 2022

    DIA_CENTRAL:T2D Treatment Pattern in Central Europe

    Completed
    • Diabetes Mellitus, Type 2
    • Byala, Bulgaria
    • +176 more
    Feb 18, 2022

    Solid Malignancy, Lymphoma Trial in New York ([18F] 4-L-Fluoroglutamine (2S,4R))

    Recruiting
    • Solid Malignancy
    • Lymphoma
    • [18F] 4-L-Fluoroglutamine (2S,4R)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 28, 2022

    PLA2R-IgG4 Detection Kit

    Enrolling by invitation
    • Membranous Nephropathy - PLA2R Induced
    • Kidney Diseases-except Membranous Nephropathy
      • Hangzhou, China
        ZhejiangBiostar
      May 6, 2023

      Chronic Hand Eczema (CHE) Trial in Worldwide (Ruxolitinib cream, Vehicle)

      Withdrawn
      • Chronic Hand Eczema (CHE)
      • Birmingham, Alabama
      • +38 more
      Nov 7, 2022

      Familial Chylomicronemia Syndrome Trial in Worldwide (Olezarsen, Placebo)

      Active, not recruiting
      • Familial Chylomicronemia Syndrome
      • Huntington Beach, California
      • +47 more
      Aug 6, 2022